loading
전일 마감가:
$38.06
열려 있는:
$38.76
하루 거래량:
512.72K
Relative Volume:
1.01
시가총액:
$725.88M
수익:
$1.77M
순이익/손실:
$-123.74M
주가수익비율:
-4.3882
EPS:
-9.17
순현금흐름:
$-95.21M
1주 성능:
+11.78%
1개월 성능:
+8.43%
6개월 성능:
-41.11%
1년 성능:
-25.70%
1일 변동 폭
Value
$38.21
$40.84
1주일 범위
Value
$35.34
$40.84
52주 변동 폭
Value
$26.70
$91.83

Praxis Precision Medicines Inc Stock (PRAX) Company Profile

Name
명칭
Praxis Precision Medicines Inc
Name
전화
617-300-8460
Name
주소
99 HIGH STREET, 30TH FLOOR, BOSTON
Name
직원
82
Name
트위터
Name
다음 수익 날짜
2024-11-06
Name
최신 SEC 제출 서류
Name
PRAX's Discussions on Twitter

PRAX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
PRAX
Praxis Precision Medicines Inc
40.24 725.88M 1.77M -123.74M -95.21M -9.17
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
501.15 126.96B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
605.61 65.06B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ARGX
Argen X Se Adr
649.67 37.54B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
259.39 32.56B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
255.77 26.40B 3.81B -644.79M -669.77M -6.24

Praxis Precision Medicines Inc Stock (PRAX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-03-03 재확인 H.C. Wainwright Buy
2025-02-11 개시 Deutsche Bank Buy
2024-08-05 개시 Oppenheimer Outperform
2024-06-24 개시 Needham Buy
2024-06-18 개시 Guggenheim Buy
2024-05-01 개시 Robert W. Baird Outperform
2023-09-19 개시 Truist Buy
2022-06-06 다운그레이드 Wedbush Outperform → Neutral
2021-12-16 개시 H.C. Wainwright Buy
2021-08-26 개시 BofA Securities Buy
2021-04-26 개시 William Blair Outperform
2020-11-11 개시 Wedbush Outperform
2020-11-10 개시 Cowen Outperform
2020-11-10 개시 Evercore ISI Outperform
2020-11-10 개시 Piper Sandler Overweight
모두보기

Praxis Precision Medicines Inc 주식(PRAX)의 최신 뉴스

pulisher
May 02, 2025

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | PRAX Stock News - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Praxis Precision Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - marketscreener.com

May 02, 2025
pulisher
May 02, 2025

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

May 02, 2025
pulisher
May 02, 2025

Praxis Precision Medicines Awards 3,688 Restricted Stock Units to 5 New Non-Executive Hires - Stock Titan

May 02, 2025
pulisher
May 02, 2025

PRAX Revenue Falls Short as Company Focuses on Epilepsy Portfoli - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Praxis Precision Medicines Provides Corporate Update and Reports - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Praxis Precision Medicines, Inc. SEC 10-Q Report - TradingView

May 02, 2025
pulisher
May 02, 2025

Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2025 Financial Results - Yahoo Finance

May 02, 2025
pulisher
May 02, 2025

Wells Fargo & Company MN Boosts Stake in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - Defense World

May 02, 2025
pulisher
May 01, 2025

Assessing Praxis Precision Medicine: Insights From 8 Financial Analysts - Benzinga

May 01, 2025
pulisher
May 01, 2025

PRAX: HC Wainwright Reiterates Buy Rating and $105 Price Target | PRAX Stock News - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Praxis Precision Medicines Inc (PRAX)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - DWinneX

May 01, 2025
pulisher
May 01, 2025

A closer look at Praxis Precision Medicines Inc (PRAX) is warranted - uspostnews.com

May 01, 2025
pulisher
Apr 30, 2025

JPMorgan Chase & Co. Has $746,000 Stock Holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - Defense World

Apr 30, 2025
pulisher
Apr 21, 2025

Praxis Precision Medicines (NASDAQ:PRAX) vs. Dr. Reddy’s Laboratories (NYSE:RDY) Head to Head Comparison - Defense World

Apr 21, 2025
pulisher
Apr 20, 2025

How To Trade (PRAX) - news.stocktradersdaily.com

Apr 20, 2025
pulisher
Apr 20, 2025

Financial Review: Praxis Precision Medicines (NASDAQ:PRAX) & ABIVAX Société Anonyme (NASDAQ:ABVX) - Defense World

Apr 20, 2025
pulisher
Apr 18, 2025

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Apr 18, 2025
pulisher
Apr 17, 2025

Geode Capital Management LLC Has $31.31 Million Stock Position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - Defense World

Apr 17, 2025
pulisher
Apr 17, 2025

Contrasting Praxis Precision Medicines (NASDAQ:PRAX) & Generex Biotechnology (OTCMKTS:GNBT) - Defense World

Apr 17, 2025
pulisher
Apr 14, 2025

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World

Apr 14, 2025
pulisher
Apr 13, 2025

Alliancebernstein L.P. Buys 60,587 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - Defense World

Apr 13, 2025
pulisher
Apr 11, 2025

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Shares Purchased by American Century Companies Inc. - Defense World

Apr 11, 2025
pulisher
Apr 10, 2025

Vanguard Group Inc. Buys 24,645 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - Defense World

Apr 10, 2025
pulisher
Apr 10, 2025

Praxis Precision Medicines Inc [PRAX] stock was sold by Nemiroff Alex at the price of US$0.66 million - knoxdaily.com

Apr 10, 2025
pulisher
Apr 09, 2025

Sodium Channel Blockers Clinical Trial Pipeline Accelerates as 20+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight - GlobeNewswire Inc.

Apr 09, 2025
pulisher
Apr 09, 2025

Is Praxis Precision Medicines Inc (PRAX) a good investment opportunity? - uspostnews.com

Apr 09, 2025
pulisher
Apr 09, 2025

Norges Bank Purchases New Stake in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - Defense World

Apr 09, 2025
pulisher
Apr 08, 2025

Praxis Precision Medicines to Hold Virtual Investor Event - GlobeNewswire

Apr 08, 2025
pulisher
Apr 08, 2025

Deep Dive Into Praxis Precision Medicine Stock: Analyst Perspectives (8 Ratings) - Benzinga

Apr 08, 2025
pulisher
Apr 08, 2025

Major Clinical Updates: Praxis Unveils New Data from 3 Rare Epilepsy Programs - Stock Titan

Apr 08, 2025
pulisher
Apr 08, 2025

KLP Kapitalforvaltning AS Buys Shares of 2,800 Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - Defense World

Apr 08, 2025
pulisher
Apr 08, 2025

Critical Survey: Praxis Precision Medicines (NASDAQ:PRAX) versus Sycamore Entertainment Group (OTCMKTS:SEGI) - Defense World

Apr 08, 2025
pulisher
Apr 07, 2025

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Shares Sold by Corebridge Financial Inc. - Defense World

Apr 07, 2025
pulisher
Apr 07, 2025

PRAX stock touches 52-week low at $30 amid market challenges - Investing.com India

Apr 07, 2025
pulisher
Apr 04, 2025

How to Take Advantage of moves in (PRAX) - news.stocktradersdaily.com

Apr 04, 2025
pulisher
Apr 04, 2025

Praxis Precision Medicines to Participate in Upcoming April Conferences - The Manila Times

Apr 04, 2025
pulisher
Apr 03, 2025

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - MarketScreener

Apr 03, 2025
pulisher
Apr 03, 2025

CNS Drug Developer Praxis Sets Key Investor Presentations at Needham and Piper Conferences - Stock Titan

Apr 03, 2025
pulisher
Apr 03, 2025

Praxis Grants 8,763 Shares to New Employees in Compensation Package - Stock Titan

Apr 03, 2025
pulisher
Apr 02, 2025

Teacher Retirement System of Texas Invests $305,000 in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - Defense World

Apr 02, 2025
pulisher
Mar 31, 2025

We're Not Very Worried About Praxis Precision Medicines' (NASDAQ:PRAX) Cash Burn Rate - Yahoo Finance

Mar 31, 2025
pulisher
Mar 29, 2025

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Shares Purchased by Swiss National Bank - Defense World

Mar 29, 2025
pulisher
Mar 27, 2025

PRAX: Riding the Market Waves of Growth and Decline in 2023 - investchronicle.com

Mar 27, 2025
pulisher
Mar 24, 2025

Praxis Precision Medicines to Present Late-Stage Data on CNS Disorders at AAN 2025 Annual Meeting - Nasdaq

Mar 24, 2025
pulisher
Mar 24, 2025

Praxis Precision Medicines to Present on Late-Stage Programs across Epilepsy and Movement Disorders at the American Academy of Neurology 2025 Annual Meeting - GlobeNewswire

Mar 24, 2025
pulisher
Mar 24, 2025

Major Clinical Updates: Praxis Unveils Late-Stage Data for Epilepsy and Movement Disorders at AAN 2025 - Stock Titan

Mar 24, 2025
pulisher
Mar 22, 2025

Charles Schwab Investment Management Inc. Acquires 5,840 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - Defense World

Mar 22, 2025
pulisher
Mar 20, 2025

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Shares Sold by Bank of New York Mellon Corp - Defense World

Mar 20, 2025
pulisher
Mar 20, 2025

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World

Mar 20, 2025
pulisher
Mar 18, 2025

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Shares Sold by US Bancorp DE - Defense World

Mar 18, 2025

Praxis Precision Medicines Inc (PRAX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Praxis Precision Medicines Inc 주식 (PRAX) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Nemiroff Alex
General Counsel and Secretary
Nov 14 '24
Sale
80.20
8,239
660,827
10,301
Mastrocola Lauren
Principal Accounting Officer
Nov 14 '24
Option Exercise
56.94
4,374
249,056
10,801
Mastrocola Lauren
Principal Accounting Officer
Nov 14 '24
Sale
81.78
5,188
424,318
5,613
$72.30
price down icon 0.47%
$21.48
price up icon 2.63%
$32.89
price up icon 1.26%
$27.90
price up icon 13.09%
$104.94
price up icon 2.45%
biotechnology ONC
$255.77
price up icon 0.05%
자본화:     |  볼륨(24시간):